Citeline recently introduced a new Therapeutic Class called "Adoptive cell therapy", enabling more granular searching capabilities to hone in on this exciting cancer immunotherapy that is expanding the horizon of personalized medicine
We’ve made the valuable and trustworthy content of Sitetrove and Trialtrove even better via the enhanced features of the new platform.
The sleek, modern, and intuitive new platform gives users faster, more efficient access to the robust and reliable data within Trialtrove and Sitetrove, while customizable search and display features allow for a deeper dive into the data that is most meaningful.
Trialtrove and Sitetrove users enjoy the same unlimited, superior support our Ask the Analyst service has always offered: our renowned team delivers answers in less than a day, on average, and the majority with a complete answer delivered.
View our informative video, and learn how the unparalleled data, outstanding support, and redesigned platform of Citeline’s Trialtrove and Sitetrove can become your essential tools for clinical trial success.
Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: